Assessing the Impact of a Novel Smartphone Application Compared With Standard Follow-Up on Mobility of Patients With Knee Osteoarthritis Following Treatment With Hylan G-F 20: A Randomized Controlled Trial

doi:10.2196/mhealth.7179

JMIR Publications

JMIR mHealth and uHealth

Impact Factor 5.0

Browse by Year:

Browse:
Issues
Authors
Themes

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.

JMIR mHealth and uHealth

Impact Factor 5.0

Published on 09.05.17 in Vol 5, No 5 (2017): May

This paper is in the following e-collection/theme issue:

Tweetations for "Assessing the Impact of a Novel Smartphone Application Compared With Standard Follow-Up on Mobility of Patients With Knee Osteoarthritis Following Treatment With Hylan G-F 20: A Randomized Controlled Trial"

Nebojsa Skrepnik, Andrew Spitzer, Roy Altman, John Hoekstra, John Stewart, Richard Toselli

JMIR Mhealth Uhealth 2017 (May 09); 5(5):e64

Tweets 1 - 12 of 12.

Tweets 1 - 12 of 12. 1

JMIR mHealth and uHealth

Citing this Article

Published on 09.05.17 in Vol 5, No 5 (2017): May

This paper is in the following e-collection/theme issue:

Tweetations for "Assessing the Impact of a Novel Smartphone Application Compared With Standard Follow-Up on Mobility of Patients With Knee Osteoarthritis Following Treatment With Hylan G-F 20: A Randomized Controlled Trial"

Tweets 1 - 12 of 12.